Tracking pancreatic cancer through all treatment stages
Part of Cancer clinical trials.
This study follows patients with non-metastatic pancreatic cancer that cannot be removed right away. It aims to understand how the disease changes during treatment, which may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer that has not spread to other organs
- Your tumor is borderline or locally advanced, meaning surgery is not immediately possible
- You have not had surgery or chemotherapy for this cancer before
- You are over 18 years old
- You are in good enough health to receive medical treatment or surgery
- You are being treated at the Paoli-Calmettes Institute
- You agree to participate and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
This study looks at how the metabolism of pancreatic cancer cells affects their surroundings. It uses a biopsy (removing a small sample of tissue from a tumor in the pancreas, liver, or lung) to learn more about the cancer and guide treatment.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This study collects medical and lab information from adults with pancreatic cancer to help researchers understand care and outcomes. You may be asked for follow-up visits and basic data, and it may be used to improve future treatments.
This trial is for people who had surgery for pancreatic cancer and are now deciding on maintenance therapy. A special blood test (ctDNA) may help doctors choose the best follow-up treatment to prevent the cancer from coming back.
Hear when a new Pancreatic Cancer Non-resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.